Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$401M |
| 2 |
NVIDIA
NVDA
|
$333M |
| 3 |
Costco
COST
|
$236M |
| 4 |
Amazon
AMZN
|
$215M |
| 5 |
Johnson & Johnson
JNJ
|
$160M |
Top Sells
| 1 |
Broadcom
AVGO
|
$322M |
| 2 |
Super Micro Computer
SMCI
|
$284M |
| 3 |
JPMorgan Chase
JPM
|
$178M |
| 4 |
WIRE
Encore Wire Corp
WIRE
|
$160M |
| 5 |
Intel
INTC
|
$152M |
Sector Composition
| 1 | Technology | 19.73% |
| 2 | Financials | 17.51% |
| 3 | Industrials | 12.49% |
| 4 | Consumer Discretionary | 10.71% |
| 5 | Healthcare | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3226
NextCure
NXTC
$13M
| $118K | ﹤0.01% |
7,154
-59
| -0.8% | -$970 |
|
|
GRTS
3227
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $116K | ﹤0.01% |
199,558
| – | – |
|
3228
enVVeno Medical
NVNO
$14.9M
| $112K | ﹤0.01% |
33,193
+16,782
| +102% | +$56.4K |
|
3229
Optex Systems
OPXS
$80M
| $110K | ﹤0.01% |
+14,457
| New | +$110K |
|
3230
Data Storage Corp
DTST
$32.4M
| $108K | ﹤0.01% |
28,593
+16,495
| +136% | +$62.2K |
|
3231
Broadway Financial
BYFC
$71.3M
| $108K | ﹤0.01% |
+16,709
| New | +$108K |
|
3232
Lightbridge
LTBR
$369M
| $107K | ﹤0.01% |
38,317
+19,279
| +101% | +$54K |
|
|
IMMP
3233
Immutep
IMMP
$242M
| $106K | ﹤0.01% |
47,940
-22,065
| -32% | -$48.8K |
|
3234
Willamette Valley Vineyards
WVVI
$24.3M
| $104K | ﹤0.01% |
29,941
-3,743
| -11% | -$13K |
|
3235
Tandy Leather Factory
TLF
$24.8M
| $104K | ﹤0.01% |
24,809
+2,114
| +9% | +$8.86K |
|
|
BMTX
3236
DELISTED
BM Technologies, Inc.
BMTX
| $103K | ﹤0.01% |
30,300
+7,194
| +31% | +$24.5K |
|
|
WHLM
3237
DELISTED
Wilhelmina International, Inc
WHLM
| $99.6K | ﹤0.01% |
23,320
| – | – |
|
3238
KORU Medical Systems
KRMD
$188M
| $98.8K | ﹤0.01% |
36,200
| – | – |
|
|
PFIE
3239
DELISTED
Profire Energy, Inc
PFIE
| $98.7K | ﹤0.01% |
58,764
| – | – |
|
|
LUMO
3240
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $97.8K | ﹤0.01% |
25,278
-4,309
| -15% | -$16.7K |
|
3241
IZEA Worldwide
IZEA
$60.7M
| $97.8K | ﹤0.01% |
35,564
+19,823
| +126% | +$54.5K |
|
3242
PDS Biotechnology
PDSB
$56.4M
| $96.6K | ﹤0.01% |
25,298
-14,335
| -36% | -$54.8K |
|
3243
NET Power
NPWR
$171M
| $96.5K | ﹤0.01% |
+13,771
| New | +$96.5K |
|
3244
Actinium Pharmaceuticals
ATNM
$49.3M
| $96.4K | ﹤0.01% |
51,284
-60,585
| -54% | -$114K |
|
3245
Lazydays
GORV
$10.6M
| $95K | ﹤0.01% |
2,111
-341
| -14% | -$15.3K |
|
3246
Medallion Financial
MFIN
$249M
| $93.2K | ﹤0.01% |
11,451
| – | – |
|
|
CLYM
3247
Climb Bio, Inc. Common Stock
CLYM
$162M
| $93K | ﹤0.01% |
18,280
+5,720
| +46% | +$29.1K |
|
|
VISL
3248
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
| $92.3K | ﹤0.01% |
+14,721
| New | +$92.3K |
|
3249
Exagen
XGN
$213M
| $92.1K | ﹤0.01% |
29,787
+8,748
| +42% | +$27K |
|
3250
Aclaris Therapeutics
ACRS
$227M
| $88.3K | ﹤0.01% |
76,810
+51
| +0.1% | +$59 |
|